Humacyte, Inc. Warrant (HUMAW)

• Market cap: $77.6M
• 1 day: -1.96%
• 5 days: 17.26%
• 1 month: -16.67%
• 3 months: 19.99%
• 6 months: -69.33%
• Year to date: -70.41%
• 1 year: -75.49%
• 5 years: -33.30%
• 10 years: -33.30%
• Sector: Healthcare
• Industry: Biotechnology

About: Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.

Employees: 220

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0% more funds holding

Funds holding: 5 [Q4 2024] → 5 (+0) [Q1 2025]

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.01% less ownership

Funds ownership: 0.37% [Q4 2024] → 0.35% (-0.01%) [Q1 2025]

81% less capital invested

Capital invested by funds: $806K [Q4 2024] → $157K (-$650K) [Q1 2025]